AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Palbociclib in South Africa

12 products registered with SAHPRA — 12 active

Brand / ProductReg. No.HolderStatusExpires
PALBOCICLIB 125 mg TABLETS PFIZER56/26/1069.1066Pfizer Laboratories (Pty) Ltdactive4 Mar 2030
IBRANCE TABLETS 75 mg56/26/1064PFIZER LABORATORIES PFE (PTY) LTDactive4 Mar 2030
IBRANCE TABLETS 100 mg56/26/1065Pfizer Laboratories (Pty) Ltdactive4 Mar 2030
IBRANCE TABLETS 125 mg56/26/1066Pfizer Laboratories (Pty) Ltdactive4 Mar 2030
PALBOCICLIB 75 mg TABLETS PFIZER56/26/1067.1064Pfizer Laboratories (Pty) Ltdactive4 Mar 2030
PALBOCICLIB 100 mg TABLETS PFIZER56/26/1068.1065Pfizer Laboratories (Pty) Ltdactive4 Mar 2030
PALBOCICLIB 75 mg CIPLA56/26/0161Cipla Medpro (Pty) Ltdactive28 Feb 2028
PALBOCICLIB 100 mg CIPLA56/26/0162Cipla Medpro (Pty) Ltdactive28 Feb 2028
PALBOCICLIB 125 mg CIPLA56/26/0163Cipla Medpro (Pty) Ltdactive28 Feb 2028
IPALIB 75 mg56/26/0164.161Cipla Medpro (Pty) Ltdactive28 Feb 2028
IPALIB 100 mg56/26/0165.162Cipla Medpro (Pty) Ltdactive28 Feb 2028
IPALIB 125 mg56/26/0166.163Cipla Medpro (Pty) Ltdactive28 Feb 2028

Palbociclib — SAHPRA Registration Details

SAHPRA (South Africa) has 12 registered products containing Palbociclib, of which 12 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Palbociclib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.